rs2230147

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003334.4(UBA1):​c.2220G>A​(p.Pro740Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0155 in 1,209,034 control chromosomes in the GnomAD database, including 1,785 homozygotes. There are 5,067 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.082 ( 923 hom., 2445 hem., cov: 22)
Exomes 𝑓: 0.0087 ( 862 hom. 2622 hem. )

Consequence

UBA1
NM_003334.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.28

Publications

3 publications found
Variant links:
Genes affected
UBA1 (HGNC:12469): (ubiquitin like modifier activating enzyme 1) The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]
UBA1 Gene-Disease associations (from GenCC):
  • infantile-onset X-linked spinal muscular atrophy
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • inflammatory disease
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-47210862-G-A is Benign according to our data. Variant chrX-47210862-G-A is described in ClinVar as [Benign]. Clinvar id is 368342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.28 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UBA1NM_003334.4 linkc.2220G>A p.Pro740Pro synonymous_variant Exon 19 of 26 ENST00000335972.11 NP_003325.2 P22314-1A0A024R1A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UBA1ENST00000335972.11 linkc.2220G>A p.Pro740Pro synonymous_variant Exon 19 of 26 1 NM_003334.4 ENSP00000338413.6 P22314-1
UBA1ENST00000377351.8 linkc.2220G>A p.Pro740Pro synonymous_variant Exon 19 of 26 1 ENSP00000366568.4 P22314-1
UBA1ENST00000377269.3 linkc.564G>A p.Pro188Pro synonymous_variant Exon 3 of 10 2 ENSP00000366481.3 Q5JRR6

Frequencies

GnomAD3 genomes
AF:
0.0812
AC:
9036
AN:
111280
Hom.:
917
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.281
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0332
Gnomad ASJ
AF:
0.00302
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000745
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0212
Gnomad NFE
AF:
0.000980
Gnomad OTH
AF:
0.0656
GnomAD2 exomes
AF:
0.0229
AC:
4140
AN:
181091
AF XY:
0.0144
show subpopulations
Gnomad AFR exome
AF:
0.282
Gnomad AMR exome
AF:
0.0135
Gnomad ASJ exome
AF:
0.00188
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000706
Gnomad OTH exome
AF:
0.00916
GnomAD4 exome
AF:
0.00875
AC:
9603
AN:
1097700
Hom.:
862
Cov.:
32
AF XY:
0.00722
AC XY:
2622
AN XY:
363092
show subpopulations
African (AFR)
AF:
0.287
AC:
7571
AN:
26377
American (AMR)
AF:
0.0157
AC:
551
AN:
35166
Ashkenazi Jewish (ASJ)
AF:
0.00175
AC:
34
AN:
19379
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30189
South Asian (SAS)
AF:
0.00111
AC:
60
AN:
54032
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40488
Middle Eastern (MID)
AF:
0.0193
AC:
80
AN:
4136
European-Non Finnish (NFE)
AF:
0.000349
AC:
294
AN:
841866
Other (OTH)
AF:
0.0220
AC:
1012
AN:
46067
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
349
698
1048
1397
1746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0815
AC:
9077
AN:
111334
Hom.:
923
Cov.:
22
AF XY:
0.0729
AC XY:
2445
AN XY:
33562
show subpopulations
African (AFR)
AF:
0.282
AC:
8561
AN:
30362
American (AMR)
AF:
0.0333
AC:
351
AN:
10555
Ashkenazi Jewish (ASJ)
AF:
0.00302
AC:
8
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3554
South Asian (SAS)
AF:
0.000748
AC:
2
AN:
2675
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6051
Middle Eastern (MID)
AF:
0.0233
AC:
5
AN:
215
European-Non Finnish (NFE)
AF:
0.000980
AC:
52
AN:
53079
Other (OTH)
AF:
0.0648
AC:
98
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
237
474
712
949
1186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0275
Hom.:
1096
Bravo
AF:
0.0940

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Infantile-onset X-linked spinal muscular atrophy Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 04, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.0020
DANN
Benign
0.75
PhyloP100
-3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230147; hg19: chrX-47070261; COSMIC: COSV107430043; COSMIC: COSV107430043; API